Maa: Australia
Kieli: englanti
Lähde: Department of Health (Therapeutic Goods Administration)
oxymetazoline hydrochloride, Quantity: 0.25 mg/mL
Medis Pharma Pty Ltd
oxymetazoline hydrochloride
Spray, nasal
Excipient Ingredients: benzalkonium chloride; disodium edetate; dibasic sodium phosphate heptahydrate; sodium chloride; sodium hydroxide; hydrochloric acid; citric acid monohydrate; purified water
Nasal
12mL
(S2) Pharmacy Medicine
Symptomatic relief of nasal and nasopharyngeal congestion associated with common cold, hay fever and sinusitis, and to facilitate visual intranasal examination. By decreasing congestion around the eustachian tube ostia, At-Eze Nasal Spray may be useful in the adjunctive treatment of congestion with middle ear conditions.
Visual Identification: Clear colourless solution.; Container Type: Aerosol - Pump Actuated Metered Dose; Container Life Time: 18 Months; Container Temperature: Store below 30 degrees Celsius
Licence status A
2004-05-19